While fans are still enjoying the freshly released Horizon Zero Dawn Remastered, whispers of a new Horizon title are already circulating. A recent job listing has sparked speculation that a Horizon-themed multiplayer game could be on its way as early as next year. Guerrilla Games, the studio behind the Horizon…
The introduction of tiltrotor technology, a novel aircraft type for the British Army, is set to bring about a "step-change" in both operational capabilities and the wider defence industrial base. This is particularly true for the Bell Future Long Range Assault Aircraft (FLRAA), a project that is currently…
Fort Lauderdale, Florida, 14 November 2024 â Atlas Ocean Voyages, a leading yacht expedition cruise company, has announced its 2026 summer itinerary collection, showcasing exciting new expeditions across Canada, Bermuda, the Caribbean, and Europe. The expanded portfolio features 28 new ports of call, providing both returning and new guests with…
The refurbishment of Darlington railway station is progressing as planned, with the completion of a new concourse. The Eastern concourse, a modern addition connected to the Grade II listed original station via an elevated walkway, marks a significant milestone in the £140 million redevelopment project. The next phase, focused…
A seasonal ice rink in Milton Keynes has become a talking point, not for its festive cheer, but for an unusual sight: a bright pink iPhone encased in two inches of ice. The "tourist attraction" at Willen on Ice has captured the attention of skaters and the media…
Catapult, a leading provider of performance technology for elite sport, has announced a 20% increase in its Annualised Contract Value (ACV) for the half-year ending 30 September 2024, accompanied by significant growth in revenue and free cash flow. The company reported an ACV of USD $96.8 million for the…
The food certification market is predicted to grow significantly in the coming years, with a projected value of £6.2 billion by 2029. This represents a compound annual growth rate (CAGR) of 5.7% from its estimated value of £4.7 billion in 2024, according to a new…
The global market for treatments for chemotherapy-induced peripheral neuropathy (CIPN) is experiencing significant growth, with a projected value of £2.1 billion by 2028. This represents a compound annual growth rate (CAGR) of 6.4% from its estimated value of £1.3 billion in 2021. This insightful report…
